Deep vein thrombosis in upper extremities: Clinical characteristics, management strategies and long-term outcomes from the COMMAND VTE Registry.
Aged
Anticoagulants
/ therapeutic use
Disease Management
Female
Humans
Japan
/ epidemiology
Male
Middle Aged
Neoplasms
/ complications
Pulmonary Embolism
/ complications
Recurrence
Registries
Retrospective Studies
Risk Factors
Upper Extremity Deep Vein Thrombosis
/ complications
Venous Thromboembolism
/ epidemiology
Bleeding
Deep vein thrombosis
Mortality
Recurrence
Upper
Journal
Thrombosis research
ISSN: 1879-2472
Titre abrégé: Thromb Res
Pays: United States
ID NLM: 0326377
Informations de publication
Date de publication:
May 2019
May 2019
Historique:
received:
15
01
2019
revised:
18
02
2019
accepted:
23
02
2019
pubmed:
3
3
2019
medline:
7
1
2020
entrez:
3
3
2019
Statut:
ppublish
Résumé
There is a paucity of data on patients with deep vein thrombosis (DVT) in upper extremities. The COMMAND VTE Registry is a retrospective multicenter registry enrolling 3027 consecutive patients with acute symptomatic venous thromboembolism (VTE) in Japan. The current study population included 2498 patients with upper or lower extremities DVT. There were 74 patients (3.0%) with upper extremities DVT and 2424 patients with lower extremities DVT. Patients with upper extremities DVT more often had active cancer (58%) and central venous catheter use (22%). The proportion of concomitant pulmonary embolism at diagnosis was lower in patients with upper extremities DVT than in those with lower extremities DVT (14% and 51%, P < 0.001). Discontinuation of anticoagulation therapy was more frequent in patients with upper extremities DVT (63.8% and 29.8% at 1-year, P < 0.001). The cumulative 3-year incidence of recurrent VTE was not different between the 2 groups (9.8% and 7.4%, P = 0.43). After adjusting confounders, the risks of upper extremities DVT relative to lower extremities DVT for recurrent VTE remained insignificant (HR 0.94, 95%CI 0.36-2.01, P = 0.89). The prevalence of patients with DVT in upper extremities was 3.0% in the current large-scale real-world registry. Patients with DVT in upper extremities more often had active cancer at diagnosis and central venous catheter use as a transient risk factor for VTE, and less often had concomitant PE. Patients with DVT in upper extremities had similar long-term risk for recurrent VTE as those with DVT in lower extremities despite shorter duration of anticoagulation.
Identifiants
pubmed: 30825719
pii: S0049-3848(19)30074-X
doi: 10.1016/j.thromres.2019.02.029
pii:
doi:
Substances chimiques
Anticoagulants
0
Types de publication
Journal Article
Multicenter Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
1-9Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.